Titan Pharma adds Scott Smith and Rajinder Kumar to board
Mr. Scott Smith, president of global inflammation and immunology at Celgene Corporation, and Dr. Rajinder Kumar, CEO of MeRaD Pharmaceutical, bring to Titan extensive product development and commercialization experience in the U.S., Europe and Asia.
In his current role as president of global inflammation and immunology, Mr. Smith leads a team of over 1,300 people.
Prior to joining Celgene, Mr. Smith was vice president, general manager and head of strategic and business analysis at Biovail Pharmaceuticals Inc., where he managed commercial business units in the U.S. and Canada.
Mr. Smith also worked for nearly a decade at Pharmacia & Upjohn and the Upjohn Company in the U.S., Hong Kong and Europe. He has extensive experience in product development and commercialization as well as business development.
Mr. Smith holds a BSc in chemistry and an HBSc degree in pharmacology and toxicology from the University of Western Ontario and a Master's of International Business Management from the American Graduate School of International Management (Thunderbird).
Dr. Kumar is the founder, chairman and CEO of MeRaD Pharmaceutical in Cambridge, England, a company focused on the development of novel anti-infective products for treating drug-resistant bacterial infections.
Previously, Dr. Kumar held senior positions in big pharma, biotech and academia.
Prior to founding MeRaD, he served in various executive capacities with Dr. Reddy's Labs, Ranbaxy Laboratories Limited, Synaptic Pharmaceutical LLP, Glaxo SmithKline, and SmithKline Beecham.
Over the years Dr. Kumar has successfully launched several new products and has clinical, regulatory, and commercial experience in the U.S., European Union, Japan and other Asian countries.
He has also served on scientific advisory boards in the fields of neuroscience, anti-infectives and metabolic disorders.
Dr. Kumar received a B.S. in Human Biology from the University of London, a Master's in Ethology from the University of Birmingham, a Bachelor of Medicine and Bachelor of Surgery from the University of Dundee and an advanced diploma in Psychological Medicine from The Royal College of Surgeons and Physicians in Ireland. ■
LATEST MOVES FROM California
- AcelRx names Vincent Angotti CEO and to board
- Biocept appoints Michael Terry SVP, commercial operations
- Arena Pharma appoints three new members to board
- Granite Construction appoints three directors
- Zenefits appoints Jeff Carr as chief revenue officer
More inside POST